Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 5 | SARTHAK BIOTECH PRIVATE LIMITEDLikely | 1 | ₹52,920 |
| 2 | Schedule 9 | JACKSON LABORATORIES PRIVATE LIMITEDLikely | 1 | ₹11,658 |
| 3 | Schedule 12 | JACKSON LABORATORIES PRIVATE LIMITEDLikely | 1 | ₹45,750 |
| 4 | Schedule 15 | MODERN MEDICAL HALLLikely | 1 | ₹3.7 L |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
22 Dec 2025, 7:00 pmClosed
Nevirapine Tablets (V2) (Q2)
Acyclovir Tablets (V2) (Q2) Haloperidol Tablet (Q2)
Ondansetron Tablet (Q2) Tablet (Q2)
Acetazolamide Tablets (V2) (Q2) (Q2)
Hydrochlorothiazide Tablet (Q2)
Tenofovir Disoproxil Fumarate + Lamivudine + Dolutegravir Tablets (V2) (Q2)
Zidovudine + Lamivudine + Nevirapine Tablets (V2) (Q2) Amiodarone Tablets (V2) (Q2) (3 (3 ) ) Minimum Average Annual Turnover of the bidder (For 3 Years) 1 Lakh (s) ( ( 3 3 ))
8502529
GEM/2025/B/6816035
Two Packet Bid
Nevirapine Tablets (V2)
Punjab; Jalandhar
Item wise evaluation
PRODUCT
7 documents required · 7 mandatory
₹1 L
80%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| Nevirapine Tablets (V2) (Q2) | - | - | - |
| Acyclovir Tablets (V2) (Q2) Haloperidol Tablet (Q2) | - | - | - |
| Ondansetron Tablet (Q2) Tablet (Q2) | - | - | - |
| Acetazolamide Tablets (V2) (Q2) (Q2) | - | - | - |
| Hydrochlorothiazide Tablet (Q2) | - | - | - |
| Tenofovir Disoproxil Fumarate + Lamivudine + Dolutegravir Tablets (V2) (Q2) | - | - | - |
| Zidovudine + Lamivudine + Nevirapine Tablets (V2) (Q2) Amiodarone Tablets (V2) (Q2) (3 (3 ) ) | - | - | - |
Exempted
30 Dec 2025
29 Dec 2025
22 Dec 2025
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8502529.pdf
GEM_BID
ATC_646e3657-8850-4536-b6d01761202452617_USINGH1972.docx
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .